Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Novelos Therapeutics Appoints Dr. James Manuso to Board of Directors
August 31st, 2007
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, announced the appointment of James S. Manuso, Ph.D., to Novelos' board of directors. Dr. Manuso, Chairman, President and CEO of SuperGen, Inc. (NASDAQ: SUPG), has over 30 years of expertise in life sciences senior management, product commercialization, partnering, financing, venture management and consulting. His appointment increases the number of directors to seven, five of which are independent directors. "We are very pleased to enlist Dr. Manuso's strategic acumen on our board, as we approach the possible approval and...
Source: Drug Week (2007-08-31)
|
